217 related articles for article (PubMed ID: 12676125)
21. Serologic and molecular characterization of an abortigenic strain of equine arteritis virus isolated from infective frozen semen and an aborted equine fetus.
Balasuriya UB; Evermann JF; Hedges JF; McKeirnan AJ; Mitten JQ; Beyer JC; McCollum WH; Timoney PJ; MacLachlan NJ
J Am Vet Med Assoc; 1998 Dec; 213(11):1586-9, 1570. PubMed ID: 9838958
[TBL] [Abstract][Full Text] [Related]
22. Responses of horses vaccinated with avirulent modified-live equine arteritis virus propagated in the E. Derm (NBL-6) cell line to nasal inoculation with virulent virus.
McCollum WH
Am J Vet Res; 1986 Sep; 47(9):1931-4. PubMed ID: 3021027
[TBL] [Abstract][Full Text] [Related]
23. Transmission of the South African asinine strain of equine arteritis virus (EAV) among horses and between donkeys and horses.
Paweska JT; Aitchison H; Chirnside ED; Barnard BJ
Onderstepoort J Vet Res; 1996 Sep; 63(3):189-96. PubMed ID: 8917855
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic application of immunoperoxidase monolayer assay using monoclonal antibodies produced against equine arteritis virus 14-kDa nucleocapsid protein.
Hornyák A; Dénes B; Szeredi L; Dencsö L; Rusvai M
Hybrid Hybridomics; 2004 Dec; 23(6):368-72. PubMed ID: 15684664
[TBL] [Abstract][Full Text] [Related]
25. Equine arteritis virus derived from an infectious cDNA clone is attenuated and genetically stable in infected stallions.
Balasuriya UB; Snijder EJ; van Dinten LC; Heidner HW; Wilson WD; Hedges JF; Hullinger PJ; MacLachlan NJ
Virology; 1999 Jul; 260(1):201-8. PubMed ID: 10405372
[TBL] [Abstract][Full Text] [Related]
26. Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain.
Castillo-Olivares J; Wieringa R; Bakonyi T; de Vries AA; Davis-Poynter NJ; Rottier PJ
J Virol; 2003 Aug; 77(15):8470-80. PubMed ID: 12857916
[TBL] [Abstract][Full Text] [Related]
27. Importance of M-protein C terminus as substrate antigen for serodetection of equine arteritis virus infection.
Jeronimo C; Archambault D
Clin Diagn Lab Immunol; 2002 May; 9(3):698-703. PubMed ID: 11986280
[TBL] [Abstract][Full Text] [Related]
28. Enhanced sensitivity of an antibody competitive blocking enzyme-linked immunosorbent assay using Equine arteritis virus purified by anion-exchange membrane chromatography.
Chung CJ; Grimm AL; Wilson CL; Balasuriya UB; Chung G; Timoney PJ; Bandaranayaka-Mudiyanselage CB; Lee SS; McGuire TC
J Vet Diagn Invest; 2015 Nov; 27(6):728-38. PubMed ID: 26462762
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibodies to equine IgM improve the sensitivity of West Nile virus-specific IgM detection in horses.
Wagner B; Glaser A; Hillegas JM; Erb H; Gold C; Freer H
Vet Immunol Immunopathol; 2008 Mar; 122(1-2):46-56. PubMed ID: 18054390
[TBL] [Abstract][Full Text] [Related]
30. Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses.
Balasuriya UB; Heidner HW; Davis NL; Wagner HM; Hullinger PJ; Hedges JF; Williams JC; Johnston RE; David Wilson W; Liu IK; James MacLachlan N
Vaccine; 2002 Feb; 20(11-12):1609-17. PubMed ID: 11858869
[TBL] [Abstract][Full Text] [Related]
31. Comparison of different molecular methods for assessment of equine arteritis virus (EAV) infection: a novel one-step MGB real-time RT-PCR assay, PCR-ELISA and classical RT-PCR for detection of highly diverse sequences of Slovenian EAV variants.
Mankoc S; Hostnik P; Grom J; Toplak I; Klobucar I; Kosec M; Barlic-Maganja D
J Virol Methods; 2007 Dec; 146(1-2):341-54. PubMed ID: 17854913
[TBL] [Abstract][Full Text] [Related]
32. Development and evaluation of ELISA procedures to detect antibodies against the major envelope protein (G(L)) of equine arteritis virus.
Nugent J; Sinclair R; deVries AA; Eberhardt RY; Castillo-Olivares J; Davis Poynter N; Rottier PJ; Mumford JA
J Virol Methods; 2000 Nov; 90(2):167-83. PubMed ID: 11064117
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibodies to equine arteritis virus proteins identify the GL protein as a target for virus neutralization.
Deregt D; de Vries AA; Raamsman MJ; Elmgren LD; Rottier PJ
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2439-44. PubMed ID: 8077945
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the neutralization determinants of equine arteritis virus using recombinant chimeric viruses and site-specific mutagenesis of an infectious cDNA clone.
Balasuriya UB; Dobbe JC; Heidner HW; Smalley VL; Navarrette A; Snijder EJ; MacLachlan NJ
Virology; 2004 Apr; 321(2):235-46. PubMed ID: 15051384
[TBL] [Abstract][Full Text] [Related]
35. [Rhinopneumonia and equine viral arteritis: seroepidemiological study in the northeast of Tunisia].
Ghram A; Chabchoub A; Turki I; Boussetta M; Ibn Amor H; Ghorbel A
Arch Inst Pasteur Tunis; 1994; 71(1-2):5-12. PubMed ID: 7661652
[TBL] [Abstract][Full Text] [Related]
36. Enzyme-linked immunosorbent assay for detection of equine infectious anemia antibody to purified P26 viral protein.
Shen DT; Gorham JR; McGuire TC
Am J Vet Res; 1984 Aug; 45(8):1542-3. PubMed ID: 6089620
[TBL] [Abstract][Full Text] [Related]
37. Failure to establish chronic infection of the reproductive tract of the male horse with a South African asinine strain of equine arteritis virus (EAV).
Paweska JT
Onderstepoort J Vet Res; 1997 Mar; 64(1):17-24. PubMed ID: 9204499
[TBL] [Abstract][Full Text] [Related]
38. Aggregation-associated loss of antigenicity observed for denatured virion protein 1 of Equine rhinitis A virus in an enzyme-linked immunosorbent assay.
Kriegshäuser G; Kuechler E; Skern T
Virus Res; 2009 Jul; 143(1):130-3. PubMed ID: 19463730
[TBL] [Abstract][Full Text] [Related]
39. Assessment of correlation between in vitro CD3+ T cell susceptibility to EAV infection and clinical outcome following experimental infection.
Go YY; Cook RF; Fulgêncio JQ; Campos JR; Henney P; Timoney PJ; Horohov DW; Balasuriya UB
Vet Microbiol; 2012 May; 157(1-2):220-5. PubMed ID: 22177968
[TBL] [Abstract][Full Text] [Related]
40. Development of a fluorescent-microsphere immunoassay for detection of antibodies specific to equine arteritis virus and comparison with the virus neutralization test.
Go YY; Wong SJ; Branscum AJ; Demarest VL; Shuck KM; Vickers ML; Zhang J; McCollum WH; Timoney PJ; Balasuriya UB
Clin Vaccine Immunol; 2008 Jan; 15(1):76-87. PubMed ID: 18032597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
